SweDeliver
SweDeliver is a world leading research forum in drug delivery, focusing on new strategies for parenteral, oral and pulmonary drug delivery.
News
- New research to improve use of amphiphilic drug molecules 2021-05-18
- “The perfect challenge” • Meet this summer's SweDeliver interns 2021-05-17
- Meet our partners: Janssen Pharmaceutica 2021-05-17
- Samar Omer selected for summer internship at Orexo: “I anticipate to be part of the SweDeliver network” 2021-05-11
- Stanko Skrtic: "SweDeliver gives reason for high expectations" 2021-05-10
Seminars & Events
-
Half time seminar • Subcutaneous Administration of Biotherapeutics: Polyelectrolyte Formulations and in Vitro Methods
-
SweDeliver webinar: Insights from the Summer 2021 internship students
-
Drugging the undruggable with pulmonary delivery of nucleic acid therapeutics
-
SweDeliver webinar: DNP-NMR in pharmaceutical application
SweDeliver webinar
21 October at 12.00
Insights from the Summer 2021 internship students
Current research
Yassir Al-Tikriti
Improving the use of amphiphilic drug molecules
Voices of SweDeliver
Susanne Bredenberg, ceo
"gives us access to valuable contacts and new input"
Meet our partners
Janssen Pharmaceutica
One of the world’s leading research-based pharma companies
This is SweDeliver
SweDeliver is a world leading research and competence centre in Drug Delivery. Many novel molecules in the drug discovery and development pipeline are biological compounds such as proteins, peptides and RNA. These display problems of poor solubility, membrane permeability and low bioavailability. Thus, the Drug Delivery area is today facing tremendous challenges to develop new drug therapies.
SweDeliver was established in response to these challenges. SweDeliver is based on a multi-disciplinary collaboration between academia and industry with financial support from Vinnova (Sweden’s Innovation Agency). The Faculty of Pharmacy at Uppsala University is the academic hub of the Centre whereas our 15 industrial partners contribute with expertise and research infrastructure as well as industrial perspectives and needs within each of the three main research areas of the Centre.
SweDeliver has prioritized to focus on outstanding research challenges within
- Parenteral Drug Delivery
- Oral Drug Delivery
- Pulmonary Drug Delivery
The research will ultimately lead to development of new and improved drug therapies with respect to both efficacy and patient safety. The Centre will also further support the strong research environment and the drug delivery ecosystem in the Nordic region.
